Delivery Order 36F79721D0068-36C26124N0536
Award Date 3/21/24
Potential Completion Date 6/21/24
Potential Value $99K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Urogen Pharma Inc., a for-profit pharmaceutical company, to provide JELMYTO kits. The $98,856.06 order is part of the VA's Pharmaceuticals and Drugs Federal Supply Schedule contract and will be fulfilled by May 10, 2024. Urogen Pharma holds several other VA contract vehicles for JELMYTO, a drug used to treat low-grade upper tract urothelial cancer in veterans, including multiple...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 20 (VISN 20), awarded a delivery order to Urogen Pharma Inc. on April 24, 2025, for the supply of JELMYTO kits, an antineoplastic antibiotic pharmaceutical treatment. This delivery order, valued at $204,528.24, is structured as a firm fixed-price contract with no set-aside designation and is set to be completed by September 30, 2025. The contract operates under the Pharmaceuticals and Drugs Federal Supply Schedule...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $194,860.32 delivery order to Urogen Pharma Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the delivery of JELMYTO mitomycin and has an anticipated completion date of August 9, 2023. Placement on the Pharmaceuticals and Drugs FSS vehicle establishes pre-negotiated pricing terms for ordering agencies like the VA to...
- <p>Urogen Pharma Inc. was awarded a $97,430.16 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order is for the emergency supply of Jelmyto to the La Vergne, TN facility and has a period of performance through July 6, 2023. No set-aside designation was applied to this award made under GSA Schedule contract FSS-61-IB.</p>
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a delivery order to Urogen Pharma Inc. for Zusduri medication on December 9, 2025, with a ceiling value of $32,844.22. This firm fixed-price delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of January 9, 2026. The contract was awarded on a full and open basis with no set-aside designation. Urogen Pharma Inc., a...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 9, awarded a delivery order to Otsuka America Pharmaceutical Inc. on December 18, 2020, for an emergency acquisition of Tolvaptan (Jynarque) with a ceiling value of $10,102.19. This firm-fixed-price delivery order, with an ultimate completion date of December 30, 2020, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and performed in Potomac, Maryland. The contract includes no set-aside...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22) awarded a delivery order to Otsuka America Pharmaceutical Inc. for Tolvaptan (Jynarque) on November 18, 2020, with a ceiling value of approximately $102,800. This firm-fixed price contract, which was completed on November 23, 2021, supports the VA's mission to provide specialized pharmaceutical treatments to veterans. The delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order to Otsuka America Pharmaceutical Inc. on October 7, 2020, for the supply of Jynarque (tolvaptan) pharmaceutical product for patient treatment at a firm-fixed price of $10,099.21. This delivery order was issued without a set-aside designation and represents performance in Richmond, Virginia, with an ultimate completion date of October 8, 2020. Jynarque is a specialty pharmaceutical used to treat...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 5, awarded a delivery order to Otsuka America Pharmaceutical Inc. on October 9, 2024, for Jynarque (tolvaptan) 90mg-30mg with a ceiling value of $12,559.90. This firm-fixed-price delivery order, with an ultimate completion date of October 11, 2024, will be performed in Pittsburgh, Pennsylvania. The award carries no set-aside designation, reflecting Otsuka's status as an established pharmaceutical manufacturer...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan) on September 26, 2023, with a ceiling value of $12,224.60. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2023, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and did not utilize a set-aside designation. The product will be delivered to...